Department of Radiological Sciences, College of Applied Medical Sciences, King Saud University, Kharj, Saudi Arabia.
Saudi J Biol Sci. 2010 Apr;17(2):139-46. doi: 10.1016/j.sjbs.2010.02.007. Epub 2010 Feb 6.
Myrrh, Commiphora molmol has been used as anti-inflammatory and wound healing commercial product. Leukocyte count had been reliable indicator for clinicians to monitor progress of healing for their patients. We hypothesized that myrrh supplement participate in the activation of leukocyte proliferation pathway prior and post skin injury and gastric ulcer. The purpose of the present study was to examine long-term effect of myrrh on leukocytes proliferation before injury and during different stages of healing. Results showed that all types of leukocytes were significantly (p < 0.05) higher in the myrrh-treated groups before and during healing. The pretreatment with myrrh offered a time-dependent rise in leukocytes proliferation. Microscopic examination of blood smear from myrrh-treated rats with skin injury, showed an elevated count of middle-sized lymphocytes and neutrophils that were characterized with well-defined nuclear lobules and rich-granules cytoplasm. Furthermore, the microscopic examinations of the spleen and lymph nodes of myrrh-treated rats with skin injury, showed an increased thickness of lymphatic sheath around the arterioles in the white pulp that was associated with high density of the medium-sized lymphocytes in the secondary lymphoid follicles in the lymph nodes with engorged sinusoids. As myrrh enhanced leukocytes proliferation before injury, it can be concluded that myrrh posse's antigenic-driven responses and that indicated some foreignness or toxicity of some constituents of myrrh. Because myrrh helped to maintain the relative rise of leukocytes counts throughout healing period and that implied it activated late steps of both proliferation and differentiation pathways for all types of leukocytes during effective phase of the specific immune responses.
没药( Commiphora molmol )被用作具有抗炎和促进伤口愈合作用的商业产品。白细胞计数一直是临床医生监测患者愈合进展的可靠指标。我们假设没药补充剂参与皮肤损伤和胃溃疡前后白细胞增殖途径的激活。本研究的目的是检查没药对损伤前和愈合不同阶段白细胞增殖的长期影响。结果表明,在损伤前和愈合过程中,所有类型的白细胞在没药处理组中均显著(p<0.05)升高。没药的预处理提供了白细胞增殖的时间依赖性增加。对皮肤损伤的没药处理大鼠的血涂片进行显微镜检查,显示中等大小的淋巴细胞和中性粒细胞计数升高,其特征是核叶明显和富含颗粒的细胞质。此外,对皮肤损伤的没药处理大鼠的脾脏和淋巴结进行显微镜检查,显示小动脉周围的淋巴鞘厚度增加,白髓中的中等大小淋巴细胞密度增加,淋巴结中的次级淋巴滤泡中的窦充血。由于没药在损伤前增强了白细胞的增殖,因此可以得出结论,没药具有抗原驱动的反应,这表明没药的某些成分具有一定的异物性或毒性。因为没药有助于在整个愈合期间维持白细胞计数的相对升高,这意味着它在特定免疫反应的有效阶段激活了所有类型白细胞的增殖和分化途径的后期步骤。